These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 21302620)
1. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB Tumori; 2010; 96(5):726-33. PubMed ID: 21302620 [TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
3. Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer. Hu SL; Huang DB; Sun YB; Wu L; Xu WP; Yin S; Chen J; Jiang XD; Shen G Med Oncol; 2011 Jun; 28(2):447-54. PubMed ID: 20300977 [TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods. Cheng ZD; Hu SL; Sun YB; Xu WP; Shen G; Kong XY Chin J Cancer; 2010 Feb; 29(2):163-6. PubMed ID: 20109344 [TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas. Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237 [TBL] [Abstract][Full Text] [Related]
6. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer. Hiraki M; Kitajima Y; Sato S; Mitsuno M; Koga Y; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K Ann Surg Oncol; 2010 Apr; 17(4):1177-86. PubMed ID: 19957042 [TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients. Tozawa T; Tamura G; Honda T; Nawata S; Kimura W; Makino N; Kawata S; Sugai T; Suto T; Motoyama T Cancer Sci; 2004 Sep; 95(9):736-40. PubMed ID: 15471559 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. Chen W; Gao N; Shen Y; Cen JN J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341 [TBL] [Abstract][Full Text] [Related]
9. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer. Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642 [TBL] [Abstract][Full Text] [Related]
10. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of CHFR and MLH1 methylation in human gastric cancer. Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501 [TBL] [Abstract][Full Text] [Related]
12. Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma. Gao YJ; Xin Y; Zhang JJ; Zhou J World J Gastroenterol; 2008 Aug; 14(32):5000-7. PubMed ID: 18763281 [TBL] [Abstract][Full Text] [Related]
14. [Correlation of CpG methylation status of Runx3 with pathogenesis of gastric carcinoma]. Tang GH; Sun SW; He XS Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):314-9. PubMed ID: 22883670 [TBL] [Abstract][Full Text] [Related]
15. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Waki T; Tamura G; Sato M; Terashima M; Nishizuka S; Motoyama T Cancer Sci; 2003 Apr; 94(4):360-4. PubMed ID: 12824905 [TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics. Jeong DH; Youm MY; Kim YN; Lee KB; Sung MS; Yoon HK; Kim KT Int J Gynecol Cancer; 2006; 16(3):1234-40. PubMed ID: 16803511 [TBL] [Abstract][Full Text] [Related]
17. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma. Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between promoter methylation of Syk and Runx3 genes and postoperative recurrence and metastasis in gastric carcinoma]. Hong H; Zhou K; Fu P; Huang Q; Wang J; Yuan X; Li J Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):341-5. PubMed ID: 25030588 [TBL] [Abstract][Full Text] [Related]
19. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer. Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO Digestion; 2006; 74(2):85-90. PubMed ID: 17139167 [TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia. Honda T; Tamura G; Waki T; Kawata S; Nishizuka S; Motoyama T Br J Cancer; 2004 May; 90(10):2013-6. PubMed ID: 15138487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]